Roivant Sciences
ROIV
ROIV
205 hedge funds and large institutions have $6.38B invested in Roivant Sciences in 2023 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 88 increasing their positions, 47 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
26% more call options, than puts
Call options by funds: $29.4M | Put options by funds: $23.3M
13% more funds holding
Funds holding: 181 → 205 (+24)
4.08% more ownership
Funds ownership: 64.9% → 68.98% (+4.1%)
Holders
205
Holding in Top 10
14
Calls
$29.4M
Puts
$23.3M
Top Buyers
| 1 | +$124M | |
| 2 | +$81.3M | |
| 3 | +$73.9M | |
| 4 |
BlackRock
New York
|
+$62.5M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$42.8M |
Top Sellers
| 1 | -$117M | |
| 2 | -$117M | |
| 3 | -$57.1M | |
| 4 |
AIG
American International Group
New York
|
-$21.2M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
-$21.1M |